Neonatal hearing screening: modelling cost and effectiveness of hospital- and community-based screening
2006

Cost and Effectiveness of Newborn Hearing Screening

Sample size: 100000 publication Evidence: moderate

Author Information

Author(s): Eva Grill, Uus Kai, Hessel Franz, Davies Linda, Rod S Taylor, Juergen Wasem, Bamford John

Primary Institution: Department of Physical Medicine and Rehabilitation, University of Munich, Germany

Hypothesis

What are the costs and effectiveness of hospital versus community-based newborn hearing screening systems in England?

Conclusion

The study found that both hospital and community newborn hearing screening programs are similarly effective, but community programs are less costly.

Supporting Evidence

  • Both hospital and community programs yielded 794 quality weighted detected child months (QCM) at the age of 6 months.
  • Total costs were £3,690,000 per 100,000 screened children in hospital and £3,340,000 in community.
  • Costs per QCM were higher by £25 in hospital-based sites.
  • Probabilistic multivariate Monte Carlo simulation revealed that in nearly half of 1000 simulated trials community settings would yield higher costs than hospital settings.

Takeaway

This study looked at how much it costs to check if babies can hear in hospitals and at home, and found that checking at home is cheaper.

Methodology

A clinical effectiveness analysis using a Markov Model to assess costs and effectiveness.

Potential Biases

Limited evidence for further benefits of early diagnosis and intervention.

Limitations

The study relies on surrogate parameters for the actual burden of disease and has uncertainties regarding model parameters.

Participant Demographics

Newborn infants in England.

Digital Object Identifier (DOI)

10.1186/1472-6963-6-14

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication